Merck Scraps 'Inferior' Covid-19 Vaccines; But Shares Recover From Dip

Merck Scraps 'Inferior' Covid-19 Vaccines; But Shares Recover From Dip

Merck stock recovered from a dip Monday after the company scrapped development of two coronavirus vaccines the company said were inferior to already authorized drugs by other pharma players.